Literature DB >> 3891336

Evolving epidemiology of Pseudomonas aeruginosa infections.

A S Cross.   

Abstract

The dramatic increase in infections caused by Pseudomonas aeruginosa over the last three decades is examined in this review. By virtue of its unique growth characteristics, this organism occupies a firm niche in the hospital environment where it continues to be a major nosocomial pathogen, with particularly high rates of infection in traditionally susceptible patient subpopulations: the compromised host, patients with malignancy, cystic fibrosis, burn wounds and trauma. In recent years infection with Pseudomonas aeruginosa has become more prominent in other patient subpopulations: for example, post-surgical, pediatric and dialysis patients, as well as the elderly. A more interesting evolution in the epidemiology of infections caused by Pseudomonas aeruginosa is the appearance, often anecdotal, of new manifestations in healthy, non-hospitalized hosts e.g. the water-associated syndromes, puncture wounds, drug addiction. The need for better data on the prevalence of these infections, the required host-organism interactions and their practical impact sets an agenda for future investigation.

Entities:  

Mesh:

Year:  1985        PMID: 3891336     DOI: 10.1007/bf02013589

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  37 in total

1.  The changing pattern of life-threatening microbial disease.

Authors:  D E ROGERS
Journal:  N Engl J Med       Date:  1959-10-01       Impact factor: 91.245

Review 2.  Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.

Authors:  M Finland
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

3.  Pseudomonas arthritis and osteomyelitis.

Authors:  M H Grieco
Journal:  J Bone Joint Surg Am       Date:  1972-12       Impact factor: 5.284

4.  Pseudomonas rhinosinusitis.

Authors:  M P Fried; J H Kelly; M Strome
Journal:  Laryngoscope       Date:  1984-02       Impact factor: 3.325

5.  Erysipelaslike lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis.

Authors:  R Roberts; M M Tarpay; M I Marks; R Nitschke
Journal:  JAMA       Date:  1982-11-05       Impact factor: 56.272

6.  Pseudomonas ophthalmia neonatorum: a cause of blindness.

Authors:  G F Cole; D P Davies; D J Austin
Journal:  Br Med J       Date:  1980-08-09

7.  Case report. Pseudomonas puncture wound osteomyelitis in adults.

Authors:  W T Siebert; S Dewan; T W Williams
Journal:  Am J Med Sci       Date:  1982 Mar-Apr       Impact factor: 2.378

8.  Whirlpool-associated Pseudomonas aeruginosa urinary tract infections.

Authors:  P Salmen; D M Dwyer; H Vorse; W Kruse
Journal:  JAMA       Date:  1983-10-21       Impact factor: 56.272

9.  Malignant external otitis in infants.

Authors:  P L Cóser; A E Stamm; R C Lobo; J A Pinto
Journal:  Laryngoscope       Date:  1980-02       Impact factor: 3.325

10.  Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.

Authors:  J J Farmer; R A Weinstein; C H Zierdt; C D Brokopp
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

View more
  4 in total

1.  Detection of soluble Pseudomonas aeruginosa antigens in bronchial secretions by a coagglutination test.

Authors:  D Sofianou; J Doumboyas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

2.  Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

3.  Multivariate analysis of antibiograms for typing Pseudomonas aeruginosa.

Authors:  M Giacca; C Monti-Bragadin
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

4.  Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran.

Authors:  Somayeh Azimi; Hossein Samadi Kafil; Hossein Bannazadeh Baghi; Saeed Shokrian; Khadijeh Najaf; Mohammad Asgharzadeh; Mehdi Yousefi; Firooz Shahrivar; Mohammad Aghazadeh
Journal:  GMS Hyg Infect Control       Date:  2016-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.